Search

Your search keyword '"Brunetto M."' showing total 862 results

Search Constraints

Start Over You searched for: Author "Brunetto M." Remove constraint Author: "Brunetto M."
862 results on '"Brunetto M."'

Search Results

201. International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways

202. Fourier and wavelet spectral analysis of EMG signals in supramaximal constant load dynamic exercise

204. Absceso subperióstico y síndrome del vértice orbitario: Complicación posterior a la extracción del tercer molar mandibular

205. Absceso subperióstico y síndrome del vértice orbitario: Complicación posterior a la extracción del tercer molar mandibular

207. Uso de cidofovir en la papilomatosis respiratoria recurrente

208. Expert Consensus Conference. The screening for hepatitis C virus infection in adults in Italy, May 5-6, 2005

209. Expert Consensus Conference. The screening for hepatitis C infection in adults in Italy, May 5-6, 2005

210. Virological profiles in hepatitis B virus / hepatitis C virus co-infected patients under interferon plus ribavirin therapy

218. PS-042 - A phase 3 study comparing tenofovir alafenamide to tenofovir disoproxil fumarate in patients with HBeAg-negative, chronic hepatitis B: efficacy and safety results at week 96

219. EASL International Consensus Conference on Hepatitis B. 13-14 September, 2002 Geneva, Switzerland. Consensus statement (long version)

221. Daclatasvir combined with peginterferon alfa-2a and ribavirin for 12 or 16 weeks in patients with hepatitis C virus genotype 2 or 3 infection: COMMAND GT2/3 study

222. 1418 DACLATASVIR COMBINED WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN FOR 12 OR 16 WEEKS IN PATIENTS WITH HCV GENOTYPE 2 OR 3 INFECTION: COMMAND GT2/3 STUDY

223. Onset of plastic relaxation in the growth of Ge on Si(001) at low temperatures: Atomic-scale microscopy and dislocation modeling

224. Pathway-based analysis of primary biliary cirrhosis genome-wide association studies

228. Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants.

229. Classical HLA-DRB1 and DPB1 alleles account for HLA associations with primary biliary cirrhosis

232. Practice guidelines for the treatment of hepatitis C: recommendations from an AISF/SIMIT/SIMAST Expert Opinion Meeting.

233. Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis

234. Absceso subperióstico y síndrome del vértice orbitario: Complicación posterior a la extracción del tercer molar mandibular

236. Effect of interferon-α on progression of cirrhosis to hepatocellular carcinoma: A retrospective cohort study

237. Colchicine in chronic hepatitis B: a pilot study

238. GS06 - A Phase 3 Study of Tenofovir Alafenamide Compared with Tenofovir Disoproxil Fumarate in Patients with Hbeag-Negative, Chronic Hepatitis B: Week 48 Efficacy and Safety Results

240. FRI-180 - Gender Differences in HCV Chronic Liver Disease: A Real Life Evaluation in Piter (Piattaforma Italiana per Lo Studio Della Terapia Delle Epatiti Virali) Cohort Study

241. FRI-181 - HCV–Related Mixed Cryoglobulinemia: Data from Piter, a Nationwide Italian HCV Cohort Study

244. HCV E1E 2‐ MF 59vaccine in chronic hepatitis C patients treated with PEG ‐ IFN α2a and R ibavirin: a randomized controlled trial

245. 251 THERAPY WITH T CELL RECEPTOR GENE MODIFIED T CELLS TARGETING HBsAg-PRODUCING HCC METASTASES

246. 1418 DACLATASVIR COMBINED WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN FOR 12 OR 16 WEEKS IN PATIENTS WITH HCV GENOTYPE 2 OR 3 INFECTION: COMMAND GT2/3 STUDY

247. Uso de cidofovir en la papilomatosis respiratoria recurrente

Catalog

Books, media, physical & digital resources